BIOCHEMICAL CHARACTERIZATION OF GBS HYALURONATE LYASE
GBS 透明质酸裂解酶的生化特征
基本信息
- 批准号:2382616
- 负责人:
- 金额:$ 24.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 2000-06-30
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis Streptococcus agalactiae active sites bacterial proteins calcium binding protein chemical binding chemical cleavage chondroitin sulfates enzyme activity enzyme linked immunosorbent assay enzyme structure host organism interaction laboratory rat molecular pathology monoclonal antibody polysaccharide carbon oxygen lyase protein sequence site directed mutagenesis solvolysis spectrometry virulence
项目摘要
B streptococci (OBS) are presently the most frequent cause of
serious, often fatal, bacterial infections of neonates in the United
States and are also a common cause of peripartum maternal sepsis.
There is evidence that a hyaluronate lyase secreted by the bacteria
is important for systemic invasion and also may interfere with
some normal host defense mechanisms. Similar enzymes are
produced by the human pathogens Streptococcus pneumoniae and
Staphylococcus aureus. Information on the properties and
specificity of the GBS enzyme, therefore, may result in an
improved understanding of the invasive capacities of all three
pathogens, and possibly lead to effective means for prevention and
control of infections caused by the bacteria. The first specific aim
is to biochemically characterize GBS hyaluronate lyase. This will
involve identifying amino acids important in the active site,
identifying hyaluronan- and calcium-binding regions, and studying
the molecular basis for the observed processive mode of action of
the enzyme. Certain domains in the GBS enzyme are very similar
to hyaluronan- and calcium binding domains identified in other
proteins. The effects of replacing selected amino acid residues in
these domains using site-directed mutagenesis will be determined.
0ther candidate amino acids will be picked for replacement based
upon a variety of assays and the extent to which the residues have
been conserved in related enzymes. The second specific aim is to
determine the specificity of GBS hyaluronate lyase for chondroitin
sulfates. Preliminary experiments revealed that GBS hyaluronate
lyase cleavage of chondroitin sulfate occurs only at (31-4
galactosamidic bonds involving an unsulfated disaccharide repeat.
Such specificity makes it possible to use the enzyme in studies of
chondroitin sulfate chain sequence. This is important since it is
clear that several chondroitin sulfates have precise biological
functions that must be related to their structures. In addition,
detailed knowledge of the cleavage specificity of the enzyme will
help clarify its effects on the extracellular matrix and basement
membranes of tissues exposed to it during infection. The third
specific aim is to assess the contribution of GBS hyaluronate lyase
to the invasive potential of the bacteria. The invasive capacity of a
new GBS hyaluronate lyase-negative mutant will be compared to
that of the parental strain in a neonatal rat model of GBS lung
invasion. In addition, the ability of passively administered
antibody to the enzyme to abolish its invasion-enhancing effects
will be assessed.
B链球菌(OBS)是目前最常见的原因,
严重的,往往是致命的,细菌感染的新生儿在美国
也是围产期产妇败血症的常见原因。
有证据表明细菌分泌的透明质酸裂解酶
对系统性侵袭很重要,也可能干扰
一些正常的宿主防御机制类似的酶有
由人类病原体肺炎链球菌产生,
金黄色葡萄球菌。关于财产的信息和
因此,GBS酶的特异性可能导致
更好地了解所有这三种病毒的入侵能力
病原体,并可能导致有效的预防手段,
控制由细菌引起的感染。第一个具体目标
是对GBS透明质酸裂解酶进行生物化学表征。这将
包括鉴定在活性位点中重要的氨基酸,
识别透明质酸和钙结合区域,并研究
观察到的进行性作用模式的分子基础
酶GBS酶中的某些结构域非常相似
在其他研究中鉴定的透明质酸和钙结合结构域
proteins.替换选择的氨基酸残基的影响,
将使用定点诱变确定这些结构域。
其他候选氨基酸将被挑选用于基于
在各种测定和残留物具有的程度上,
在相关酶中是保守的。第二个具体目标是
测定GBS透明质酸裂解酶对软骨素的特异性
硫酸盐初步实验表明,GBS透明质酸
硫酸软骨素的裂解酶裂解仅发生在(31-4
包含未硫酸化的二糖重复的半乳糖糖键。
这种特异性使得有可能使用该酶研究
硫酸软骨素链序列。这一点很重要,因为
很明显,几种硫酸软骨素具有精确的生物活性,
必须与其结构相关的功能。此外,本发明还提供了一种方法,
酶的切割特异性的详细知识将
有助于阐明其对细胞外基质和基底的影响
在感染时暴露于其下的组织膜。 第三
具体目的是评估GBS透明质酸裂解酶的贡献
细菌的入侵潜力。入侵能力
新的GBS透明质酸裂解酶阴性突变体将与
在新生大鼠GBS肺模型中的亲本菌株
入侵此外,被动管理的能力
酶的抗体,以消除其入侵增强作用
将被评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID G PRITCHARD其他文献
DAVID G PRITCHARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID G PRITCHARD', 18)}}的其他基金
B. anthracis Peptidoglycan Deacetylase as a Drug Target
B. 炭疽肽聚糖脱乙酰酶作为药物靶点
- 批准号:
6916423 - 财政年份:2004
- 资助金额:
$ 24.07万 - 项目类别:
B. anthracis Peptidoglycan Deacetylase as a Drug Target
B. 炭疽肽聚糖脱乙酰酶作为药物靶点
- 批准号:
6820763 - 财政年份:2004
- 资助金额:
$ 24.07万 - 项目类别:
Inhibition of GBS Carriage by Engineered Lactobacilli
工程乳酸杆菌抑制 GBS 携带
- 批准号:
6606360 - 财政年份:2003
- 资助金额:
$ 24.07万 - 项目类别:
Inhibition of GBS Carriage by Engineered Lactobacilli
工程乳酸杆菌抑制 GBS 携带
- 批准号:
6699312 - 财政年份:2003
- 资助金额:
$ 24.07万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF GBS HYALURONATE LYASE
GBS 透明质酸裂解酶的生化特征
- 批准号:
2887507 - 财政年份:1997
- 资助金额:
$ 24.07万 - 项目类别:
BIOCHEMICAL CHARACTERIZATION OF GBS HYALURONATE LYASE
GBS 透明质酸裂解酶的生化特征
- 批准号:
2673048 - 财政年份:1997
- 资助金额:
$ 24.07万 - 项目类别:
PHASE VARIATION IN THE PATHOGENESIS OF GBS INFECTION
GBS 感染发病机制的阶段变化
- 批准号:
3145708 - 财政年份:1992
- 资助金额:
$ 24.07万 - 项目类别:
PHASE VARIATION IN THE PATHOGENESIS OF GBS INFECTION
GBS 感染发病机制的阶段变化
- 批准号:
2065800 - 财政年份:1992
- 资助金额:
$ 24.07万 - 项目类别:
PHASE VARIATION IN THE PATHOGENESIS OF GBS INFECTION
GBS 感染发病机制的阶段变化
- 批准号:
3145709 - 财政年份:1992
- 资助金额:
$ 24.07万 - 项目类别:
相似海外基金
Pre-labour invasion of the human uterus by Streptococcus agalactiae
无乳链球菌在产前侵入人类子宫
- 批准号:
MR/W025620/1 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Research Grant
Genetic screen to define the regulation of beta-hemolysin toxin expression in Streptococcus agalactiae
基因筛选以确定无乳链球菌中 β-溶血素毒素表达的调节
- 批准号:
10731405 - 财政年份:2023
- 资助金额:
$ 24.07万 - 项目类别:
Defining the impact of zinc on Streptococcus agalactiae biofilm and colonization
确定锌对无乳链球菌生物膜和定植的影响
- 批准号:
10358527 - 财政年份:2020
- 资助金额:
$ 24.07万 - 项目类别:
The Characterization of Streptococcus agalactiae Novel Protein, Sak_1753, in the Colonization of the Vaginal Tract
无乳链球菌新型蛋白 Sak_1753 在阴道定植中的表征
- 批准号:
10216957 - 财政年份:2020
- 资助金额:
$ 24.07万 - 项目类别:
The Characterization of Streptococcus agalactiae Novel Protein, Sak_1753, in the Colonization of the Vaginal Tract
无乳链球菌新型蛋白 Sak_1753 在阴道定植中的表征
- 批准号:
10442754 - 财政年份:2020
- 资助金额:
$ 24.07万 - 项目类别:
Defining the impact of zinc on Streptococcus agalactiae biofilm and colonization
确定锌对无乳链球菌生物膜和定植的影响
- 批准号:
10721139 - 财政年份:2020
- 资助金额:
$ 24.07万 - 项目类别:
Defining the impact of zinc on Streptococcus agalactiae biofilm and colonization
确定锌对无乳链球菌生物膜和定植的影响
- 批准号:
10571912 - 财政年份:2020
- 资助金额:
$ 24.07万 - 项目类别:
Role of Streptococcus agalactiae glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in infection and potential as a target to control colonization in the female genital tract
无乳链球菌甘油醛 3-磷酸脱氢酶 (GAPDH) 在感染中的作用及其作为控制女性生殖道定植目标的潜力
- 批准号:
nhmrc : 1146569 - 财政年份:2018
- 资助金额:
$ 24.07万 - 项目类别:
Project Grants
Integrated bacterial genomics and virulence analysis of uropathogenic Streptococcus agalactiae
尿路致病性无乳链球菌的综合细菌基因组学和毒力分析
- 批准号:
nhmrc : 1146820 - 财政年份:2018
- 资助金额:
$ 24.07万 - 项目类别:
Project Grants
Role of Streptococcus agalactiae glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in infection and potential as a target to control colonization in the female genital tract
无乳链球菌甘油醛 3-磷酸脱氢酶 (GAPDH) 在感染中的作用及其作为控制女性生殖道定植目标的潜力
- 批准号:
nhmrc : GNT1146569 - 财政年份:2018
- 资助金额:
$ 24.07万 - 项目类别:
Project Grants